HALO vs. SPY
Compare and contrast key facts about Halozyme Therapeutics, Inc. (HALO) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HALO or SPY.
Correlation
The correlation between HALO and SPY is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
HALO vs. SPY - Performance Comparison
Key characteristics
HALO:
1.23
SPY:
1.46
HALO:
1.77
SPY:
1.99
HALO:
1.28
SPY:
1.27
HALO:
1.33
SPY:
2.23
HALO:
3.82
SPY:
9.00
HALO:
12.70%
SPY:
2.08%
HALO:
39.49%
SPY:
12.83%
HALO:
-74.26%
SPY:
-55.19%
HALO:
-8.18%
SPY:
-3.06%
Returns By Period
In the year-to-date period, HALO achieves a 23.72% return, which is significantly higher than SPY's 1.38% return. Over the past 10 years, HALO has outperformed SPY with an annualized return of 14.23%, while SPY has yielded a comparatively lower 12.94% annualized return.
HALO
23.72%
4.84%
-7.36%
43.88%
23.63%
14.23%
SPY
1.38%
-1.79%
6.09%
17.34%
15.76%
12.94%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HALO vs. SPY — Risk-Adjusted Performance Rank
HALO
SPY
HALO vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Halozyme Therapeutics, Inc. (HALO) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HALO vs. SPY - Dividend Comparison
HALO has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.19%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HALO Halozyme Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.19% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
HALO vs. SPY - Drawdown Comparison
The maximum HALO drawdown since its inception was -74.26%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for HALO and SPY. For additional features, visit the drawdowns tool.
Volatility
HALO vs. SPY - Volatility Comparison
Halozyme Therapeutics, Inc. (HALO) has a higher volatility of 4.40% compared to SPDR S&P 500 ETF (SPY) at 3.69%. This indicates that HALO's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.